Chemours stock holds steady as investors weigh latest earnings and balance sheet

Published on 09/18/2026 at 13:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Chemours stock reflects the company’s Q2 2026 performance, with investors watching revenue trends and leverage as of August 2026. The shares also trade in the context of recent guidance and balance sheet moves from the specialty chemicals group.

CC, US1638511089, Illustration mit AI erstellt.

Chemours stock (ISIN US1638511089) gives investors a snapshot of how the specialty chemicals group’s latest reported figures and balance sheet developments up to August 2026 feed into today’s valuation as of September 18, 2026. The company’s most recent quarterly numbers and debt profile remain central to how the market prices the shares.

Latest reported figures frame Chemours stock

The Chemours Company, headquartered in Wilmington, Delaware and listed on the New York Stock Exchange under the ticker CC, last reported results for the second quarter of 2026, which ended in June 2026. In that Q2 2026 period, the group’s revenue and earnings picture provided the most recent fundamental anchor for Chemours stock, with investors focusing on how margins and cash generation support ongoing investment and debt service.

According to Chemours in its Q2 2026 reporting, the company set out revenue for that quarter and detailed segment contributions, giving the market a clear view of the latest demand trends in titanium technologies, thermal and specialized solutions, and advanced performance materials. The Q2 2026 figures also outlined operating income and net income, which investors use to assess earnings power and compare Chemours stock with other specialty chemicals names.

Debt, cash flow and guidance influence valuation

Beyond headline revenue and earnings, Chemours’ leverage and cash flow metrics in Q2 2026 have been important for how investors judge the risk profile of Chemours stock. In that Q2 2026 report, the company described its total debt and cash position and highlighted free cash flow generation for the quarter and for the first half of 2026, which matters for ongoing dividend capacity and potential debt reduction. According to Chemours, management also reiterated full year 2026 guidance ranges for adjusted earnings and free cash flow, giving investors numerical guardrails against which to measure the current share price.

For readers comparing current fundamentals with the past, the same Q2 2026 disclosure provided prior year figures for Q2 2025 and for earlier fiscal periods as a historical reference point. These historical numbers showed how Chemours’ revenue and earnings have developed over time, but for pricing Chemours stock today, investors focus primarily on the Q2 2026 values and the full year 2026 guidance, as these are the freshest quantified indicators available within nine months of September 18, 2026.

Stock level reflects most recent fundamentals

As of September 18, 2026, Chemours stock on the New York Stock Exchange trades in United States dollars with a price that reflects the balance between its Q2 2026 performance and the full year 2026 expectations. Per recent NYSE data, the CC shares are quoted with a latest price, prior close and an intraday change in percent, and the stock’s 52 week high and 52 week low show the trading corridor over the last year, with the current price positioned between those two levels as of the latest completed trading session.

Market capitalization for Chemours, calculated from the NYSE share price and the number of shares outstanding, stands in the billions of United States dollars and is dated to the same latest trading day in September 2026. Trading volume in Chemours stock, also as of the most recent session, shows how actively the shares have changed hands, giving investors a sense of liquidity when considering entry or exit. These market figures, together with the Q2 2026 fundamental data, provide a numerical framework for any comparison of Chemours stock to peers in the specialty chemicals segment or to broader indices such as the S&P 500.

Investor perspective on Chemours stock

For investors, the interplay between Chemours’ most recent quarterly revenue and earnings, its leverage and cash flow profile and the current NYSE price level as of September 18, 2026 defines the key questions around valuation. Chemours stock thus remains closely tied to the Q2 2026 results and full year 2026 guidance outlined on the company’s investor relations page and to how the share price evolves relative to its 52 week range and market capitalization.